Centogene B.V.

General Information


We are a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. Our goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. We have developed a global proprietary rare disease platform based on our real-world data repository with over 2.0 billion weighted data points from over 450,000 patients representing 115 different countries as of August 31, 2019, or an average of over 500 data points per patient. Our platform includes epidemiologic, phenotypic and genetic data that reflects a global population, and also a biobank of these patients’ blood samples.

Employees: 400
Founded: 2018
Contact Information
Address Am Strande 7,18055 Rostock, Germany
Phone Number +49 (381) 80113400
Web Address http://www.centogene.com
View Prospectus: Centogene B.V.
Financial Information
Market Cap $278.1mil
Revenues $45.4 mil (last 12 months)
Net Income $-16.3 mil (last 12 months)
IPO Profile
Symbol CNTG
Exchange NASDAQ
Shares (millions): 4.0
Price range $14.00 - $14.00
Est. $ Volume $56.0 mil
Manager / Joint Managers SVB Leerink/ Evercore
CO-Managers Baird/ BTIG
Expected To Trade: 11/7/2019
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change